Neurol India Close
 

Figure 3: Good functional outcomes (modified Rankin Scale 0–2 at 90 days). (a) Comparison of ET versus other treatment options for primary outcome: mRS 0-2 at 90 days. (b) A subgroup analysis based on the type of intervention: Comparing ET alone with IVT or standard treatment, and comparing ET plus IVT with IVT or standard treatment. (c) A subgroup analysis based on whether patients were enrolled with evidence of baseline angiography

Figure 3: Good functional outcomes (modified Rankin Scale 0–2 at 90 days). (a) Comparison of ET versus other treatment options for primary outcome: mRS 0-2 at 90 days. (b) A subgroup analysis based on the type of intervention: Comparing ET alone with IVT or standard treatment, and comparing ET plus IVT with IVT or standard treatment. (c) A subgroup analysis based on whether patients were enrolled with evidence of baseline angiography